Sign in

CIK 0001832038

  • Emerging growth company

Invivyd, Inc.

Sign in to watch
Ticker
IVVD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851403134
Phone
+1 781-819-0080
Business address
205 CHURCH STREET, NEW HAVEN, CT
Former names
Adagio Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$86,839
in 5 filings, $87K under 10b5-1 plans

Net −$86,839. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-08-10 MCGUIRE TERRANCE Director Conversion · Series B Preferred Stock −583 0
2021-08-10 MCGUIRE TERRANCE Director Conversion · Series B Preferred Stock −850 0
2021-08-10 MCGUIRE TERRANCE Director Conversion · Series B Preferred Stock −44,076 0
2021-08-10 MCGUIRE TERRANCE Director Conversion · Series C Preferred Stock −123,574 0
2021-08-10 MCGUIRE TERRANCE Director Conversion · Series C Preferred Stock −2,409 0
2021-08-10 MCGUIRE TERRANCE Director Conversion · Series C Preferred Stock −846 0
2021-08-10 MCGUIRE TERRANCE Director Conversion · Series C Preferred Stock −1,235 0
2021-08-10 MCGUIRE TERRANCE Director Conversion · Series C Preferred Stock −32,016 0
2021-08-10 MCGUIRE TERRANCE Director Conversion · Series C Preferred −64,032 0
2021-08-10 Gerngross Tillman U. Chief Executive Officer Conversion +25,860,700 27,845,995
2021-08-10 Gerngross Tillman U. Chief Executive Officer Conversion · Series A Preferred Stock −5,000,000 0
2021-08-10 Gerngross Tillman U. Chief Executive Officer Conversion · Series B Preferred Stock −44,076 0
2021-08-10 Gerngross Tillman U. Chief Executive Officer Conversion · Series C Preferred Stock −128,064 0
2021-08-10 Adimab, LLC 10% owner Conversion +25,860,700 27,845,995
2021-08-10 Adimab, LLC 10% owner Conversion · Series A Preferred Stock −5,000,000 0
2021-08-10 Adimab, LLC 10% owner Conversion · Series B Preferred Stock −44,076 0
2021-08-10 Adimab, LLC 10% owner Conversion · Series C Preferred Stock −128,064 0
2021-08-10 Redmile Group, LLC 10% owner Conversion +1,920,960 1,920,960
2021-08-10 Redmile Group, LLC 10% owner Purchase +1,470,000 $17.00 $25.0M 3,390,960
2021-08-10 Redmile Group, LLC 10% owner Conversion · Series C Preferred Stock −1,920,960 0

Page 11 of 12 · 225 trades